Can choline- and carnitine-rich foods raise TMAO levels?

Dietary intake of choline- and carnitine-rich foods (such as red meat, eggs, and dairy) directly influences systemic levels of trimethylamine N-oxide (TMAO) through a coordinated, two-step gut-hepatic pathway.

Mechanistic pathway of TMAO generation

• Microbial conversion: Dietary choline and L-carnitine that escape absorption in the small intestine serve as substrates for specific gut microbiota phyla (primarily Firmicutes, Proteobacteria, and Actinobacteria).
• Enzymatic cleavage: Bacterial enzymes convert these precursors into trimethylamine (TMA). Specifically, choline is metabolized via the microbial choline TMA-lyase complex (CutC/D), while L-carnitine is processed via the carnitine oxygenase system (CntA/B).
• Hepatic oxidation: Once produced, TMA is absorbed across the intestinal epithelium into the portal vein. In the liver, host flavin-containing monooxygenases—principally FMO3—oxidize TMA to directly generate circulating TMAO.

Cardiovascular implications

• Vascular risk: Elevated systemic TMAO levels have been shown to drive increased cardiovascular disease risk. Mechanistically, circulating TMAO promotes endothelial dysfunction, accelerates atherosclerotic plaque formation, and enhances platelet hyperreactivity. This meta-organismal pathway is highly relevant for cardiovascular risk stratification, particularly in older populations where maintaining vascular integrity and managing thrombosis risk are primary clinical goals.

Bottom line

• Strong clinical and biochemical evidence confirms that dietary choline and carnitine are metabolized by gut bacterial enzymes (CutC/D and CntA/B) into TMA, which is subsequently oxidized by hepatic FMO3 to elevate systemic TMAO and drive up cardiovascular risk.